Editas Medicine, inc (EDIT) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Operator
Good day and thank you for standing by. Welcome to the AbCellera Q1 2021 earnings results and business update conference call. [Operator instructions] I would now like to hand the conference over to your speaker today, Tryn Stimart, chief legal officer and chief compliance officer. Please go ahead.
Tryn Stimart
Chief Legal Officer and Chief Compliance Officer
Thank you. Good afternoon, everyone, and welcome to AbCellera s first-quarter 2021 business update. We are pleased to have you with us today where we will discuss the results announced in our press release issued after the market closed today, which you can find on our investor relations website. With me on the call are Dr.
Operator
Welcome to the quarter one 2021 Kura Oncology, Inc. Earnings Conference Call. My name is Jenny. I ll be your operator for today s call. [Operator Instructions] I will now turn the call over to Pete De Spain. You may begin.
Pete De Spain
Vice President, Investor Relations and Corporate Communications
Thank you, Jenny. Good afternoon, and welcome to Kura s Oncology s First Quarter 2021 Conference Call. Joining me on the call are Dr. Troy Wilson, our President and Chief Executive Officer; and Dr. Marc Grasso, our Chief Financial Officer and Chief Business Officer. Jim Basta, our Chief Legal Officer; Dr. Stephen Dale, our Chief Medical Officer, Pearson Flowers, our Chief Commercial Officer; and Kathy Ford, our Chief Operating Officer, are also with us and available to answer questions. Before I turn the call over to Dr. Wilson, I would like to remind you that today s call will include forward-looking statements based on current expectations. Such statements represent mana